CN109157519B - Preparation method of ofloxacin tablets - Google Patents
Preparation method of ofloxacin tablets Download PDFInfo
- Publication number
- CN109157519B CN109157519B CN201810597995.2A CN201810597995A CN109157519B CN 109157519 B CN109157519 B CN 109157519B CN 201810597995 A CN201810597995 A CN 201810597995A CN 109157519 B CN109157519 B CN 109157519B
- Authority
- CN
- China
- Prior art keywords
- ofloxacin
- preparation
- materials
- moisture content
- mixing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to the field of pharmaceutical preparations, and relates to a method for preparing non-sticking ofloxacin tablets aiming at the defect of sticking of ofloxacin materials. The tablet disclosed by the invention has the advantages of simple preparation method, easiness in industrialization, controllable quality, high production efficiency and the like, can be produced by adopting a conventional preparation method, does not need special equipment, and is obviously improved.
Description
Technical Field
The invention relates to the field of pharmaceutical preparations, in particular to a tablet containing ofloxacin and a preparation method thereof.
Background
Ofloxacin is a quinolone antibacterial drug, and acts on A subunit of bacterial DNA helicase to inhibit DNA synthesis and replication, so that the bacteria die. Chemical name of ofloxacin: (±) -9-fluoro-2, 3-dihydro-3-methyl-10- (4-methyl-1-piperazinyl) -7-oxo-7H-pyrido [1,2,3-de]-[1,4]Benzoxazine-6-carboxylic acid, formula: c18H20FN3O4 Molecular weight: 361.38 has the chemical structural formula:
the ofloxacin molecules contain carboxyl, the carboxyl can be tightly combined with stainless steel equipment under the catalysis of moisture to cause sticking, the ofloxacin tablet has the specification of 0.1g and accounts for about 50% of the whole tablet, the sticking phenomenon is serious in the tabletting process, the problem of sticking of the ofloxacin tablet cannot be solved due to the fact that the content of the raw material of the ofloxacin is high, the effect of adding magnesium stearate serving as a lubricant is not large, the problem of sticking of the ofloxacin tablet cannot be solved due to the fact that the type of the lubricant is changed, the traditional production method is to continuously stop equipment to clean a punch, the production efficiency is low, and the product quality cannot be guaranteed.
At present, a patent about solving the sticking problem of the ofloxacin tablet is not found, and a Chinese patent (application number 20131025966.3) discloses a method for solving the sticking problem, and discloses a sticking and punching gap bridge device for a tablet press, which needs to be modified. Other methods for solving the sticking problem of oral solid preparations comprise adopting a special adhesive (CN 2014I 10735866) and treating the raw materials with a special solvent in advance (CN 105380916), and Chinese patent application No. 201410652944.7 discloses an ofloxacin dispersible tablet, which does not mention the method provided by the invention, and treats the materials from the aspect of preparation process to solve the sticking problem.
The invention aims to provide an ofloxacin tablet and a preparation method thereof, which solve the sticking problem in the preparation process, improve the product quality and improve the production efficiency.
Disclosure of Invention
Aiming at the problems, the invention provides a preparation method of an ofloxacin tablet. The ofloxacin tablet provided by the invention contains pharmaceutically acceptable filler, adhesive, disintegrant and lubricant.
Preferably, the pharmaceutical composition provided by the invention consists of ofloxacin, corn starch, sodium carboxymethyl starch, hydroxypropyl methylcellulose and magnesium stearate.
The invention prepares the non-sticking ofloxacin tablet by the following method: mixing ofloxacin raw material and adjuvant, adding adhesive, and mixing. The mixed materials are firstly dried in advance in one step. The granules treated in this step were not sticky during tabletting. The pre-dried material is then granulated in a granulator, finally dried and compressed into tablets.
The invention also provides a preparation method of the oxyfluorsaxate tablet, which comprises the following steps:
adding ofloxacin, corn starch and sodium carboxymethyl starch into a mixing device, and uniformly mixing.
Secondly, adding a water-alcohol mixed solution of hydroxypropyl methylcellulose with certain concentration into the materials obtained in the first step, and uniformly mixing.
Thirdly, the materials obtained in the second step are pre-dried by a fluidized bed, and the end point is 3 to 15 percent (preferably 5 to 8 percent) of the moisture of the materials
And fourthly, granulating the materials which are dried in advance in the third step by using a granulator.
Fifthly, drying the material obtained in the fourth step, and adding magnesium stearate.
Sixthly, tabletting.
The specific implementation content is as follows:
example (b):
prescription:
name (R) | Amount of prescription |
Ofloxacin | 1000g |
Corn starch | 900g |
Sodium starch glycolate | 70g |
2.5% hydroxypropyl methylcellulose in 50% ethanol | 800ml (hydroxypropyl methylcellulose: 20 g) |
Magnesium stearate | 30g |
Total weight of | 2020g |
Amount of preparation | 10000 tablets |
The preparation process comprises the following steps:
adding prescription dose of ofloxacin, corn starch and sodium carboxymethyl starch into a wet granulator, mixing for 10 minutes at 70rpm, and mixing uniformly.
② adding adhesive with prescription amount, stirring at 70rpm, cutting at 1500rpm, and mixing uniformly.
And thirdly, placing the wet material obtained in the second step into fluidized bed drying equipment, controlling the air inlet temperature to be 75 ℃, setting the frequency of a fan to be 20HZ, drying for about 10 minutes, discharging, taking particles, measuring moisture, controlling the moisture to be 7%, and stopping drying the material.
Fourthly, granulating the materials obtained in the third step by using a 16-mesh sieve, and drying the granules in the fluidized bed again until the water content is 3 percent.
Fifthly, adding the magnesium stearate with the amount of the prescription into the dried material, mixing uniformly and tabletting.
Drug stability study
The ofloxacin tablet prepared by the invention has no sticking problem in the tabletting process, the content of the provided ofloxacin tablet is accelerated for 6 months, the change of related substances is not large, and the product stability is good.
Claims (3)
1. A preparation method of tablets containing ofloxacin is characterized in that: the prescription composition of every ten thousand ofloxacin tablets is as follows: 1000g of ofloxacin, 900g of corn starch, 70g of sodium carboxymethyl starch, 20g of hydroxypropyl methylcellulose and 30g of magnesium stearate;
the preparation method of the oxyfluorsaxate tablet comprises the following steps:
adding prescription dose of ofloxacin, corn starch and sodium carboxymethyl starch into a wet granulator, mixing for 10 minutes at 70rpm, and uniformly mixing;
secondly, dissolving the hydroxypropyl methylcellulose with the prescription amount in 800ml of 50% ethanol solution, adding the solution into the mixed material obtained in the first step, stirring the mixed material at 70rpm, and uniformly mixing the mixed material by a cutter at 1500 rpm;
thirdly, placing the materials obtained in the second step into fluidized bed drying equipment, controlling the air inlet temperature to be 75 ℃ and the frequency of a fan to be 20HZ, and pre-drying the materials until the moisture content of the materials is 3% -15%;
fourthly, after the materials obtained in the third step are granulated by 16 meshes, the granules are put into a fluidized bed again for drying until the moisture content is 3 percent;
fifthly, adding the magnesium stearate with the prescription amount into the material obtained in the fourth step, mixing uniformly and tabletting.
2. The preparation method of claim 1, wherein the predrying end point is that the moisture content of the material is 5% -8%;
3. the method according to claim 1, wherein the predrying end point is a material moisture content of 7%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810597995.2A CN109157519B (en) | 2018-06-12 | 2018-06-12 | Preparation method of ofloxacin tablets |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810597995.2A CN109157519B (en) | 2018-06-12 | 2018-06-12 | Preparation method of ofloxacin tablets |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109157519A CN109157519A (en) | 2019-01-08 |
CN109157519B true CN109157519B (en) | 2021-01-26 |
Family
ID=64897108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810597995.2A Expired - Fee Related CN109157519B (en) | 2018-06-12 | 2018-06-12 | Preparation method of ofloxacin tablets |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109157519B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113368072A (en) * | 2021-06-23 | 2021-09-10 | 海南海神同洲制药有限公司 | Ofloxacin coated tablet and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104257612A (en) * | 2014-09-04 | 2015-01-07 | 河南亚卫动物药业有限公司 | Long-acting ofloxacin sustained-release pellet for veterinary use and preparation method thereof |
CN104288112A (en) * | 2014-09-30 | 2015-01-21 | 地奥集团成都药业股份有限公司 | Levofloxacin hydrochloride tablets |
CN105796523A (en) * | 2016-04-19 | 2016-07-27 | 湖北午时药业股份有限公司 | Levofloxacin mesylate tablets and preparation process thereof |
-
2018
- 2018-06-12 CN CN201810597995.2A patent/CN109157519B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104257612A (en) * | 2014-09-04 | 2015-01-07 | 河南亚卫动物药业有限公司 | Long-acting ofloxacin sustained-release pellet for veterinary use and preparation method thereof |
CN104288112A (en) * | 2014-09-30 | 2015-01-21 | 地奥集团成都药业股份有限公司 | Levofloxacin hydrochloride tablets |
CN105796523A (en) * | 2016-04-19 | 2016-07-27 | 湖北午时药业股份有限公司 | Levofloxacin mesylate tablets and preparation process thereof |
Non-Patent Citations (1)
Title |
---|
氧氟沙星片工艺的研究;林惠安等;《广东药学》;20021231;第12卷(第4期);第22-24页 * |
Also Published As
Publication number | Publication date |
---|---|
CN109157519A (en) | 2019-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104523640A (en) | Ticagrelor tablets and preparation method thereof | |
CN109157519B (en) | Preparation method of ofloxacin tablets | |
Shende et al. | Studies on development of Sustained release Diltiazem hydrochloride matrices through jackfruit mucilage | |
CN104055743A (en) | Preparation method of oral preparation containing rivaroxaban | |
CN115025066B (en) | Preparation method of traditional Chinese medicine slow-release particles with stable quality and capable of resisting diarrhea of piglets | |
CN101822650A (en) | Minocycline hydrochloride sustained release tablet and preparation method thereof | |
CN111297867A (en) | Use of composition containing pyridylaminopyridopyrimidine derivative for preparing medicine for treating breast cancer | |
CN103263395A (en) | Telmisartan tablet preparation and preparation method thereof | |
CN110664771A (en) | Pharmaceutical composition containing pexaparib hydrochloride and preparation method thereof | |
CN104800177B (en) | A kind of Cefadroxil tablets and preparation method thereof | |
CN103977009A (en) | Orally-taken medicinal composition containing cefdinir and preparation method thereof | |
CN102526007A (en) | Florfenicol taste masking preparation and preparation method for same | |
CN114748435A (en) | Donepezil hydrochloride orally disintegrating tablet and preparation method thereof | |
CN110420190B (en) | Clonazepam tablets and preparation method thereof | |
CN104161734A (en) | Amoxicillin dispersible tablet as well as preparation method and use thereof | |
CN103479589A (en) | Cefpodoxime proxetil dispersible tablet and preparation method thereof | |
CN105030707B (en) | Method for preparing clotrimazole buccal tablets based on modified glucose whole powder direct compression method | |
CN116555499A (en) | Compressible sucrose particles and method for preparing same | |
CN115487158A (en) | Cytisine tablet and preparation method thereof | |
CN110051639B (en) | Rapidly disintegrating nicergoline tablet and preparation method thereof | |
CN103816129B (en) | Agomelatine orally disintegrating tablet | |
CN110876728A (en) | Preparation method of metformin hydrochloride quick-release preparation | |
CN104666263A (en) | Tablet containing levetiracetam and preparation method of tablet | |
CN103340856A (en) | Rifaximin medicine composition and preparation method thereof | |
CN115624535B (en) | Preparation method of Fudosteine tablet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20210126 Termination date: 20210612 |
|
CF01 | Termination of patent right due to non-payment of annual fee |